American HealthCare Capital is pleased to introduce a Retail and Specialty Pharmacy for sale in New York. The pharmacy has been in business for nearly 8 years. They specialize in dermatology, gastroenterology, infectious disease, and rheumatology.
The pharmacy’s payers include private insurance (70%), Medicare (25%), Medicaid (4%), and cash (1%). Gross revenues were $64 Million in 2017 with an annual script count of 58,500. In 2018, they expect to decline to $42 Million in gross revenue, which is largely due to the lower cost of Hep C drugs. However, their script count is only slightly down, with a projection of 57,000 for the year.
The asking price for this opportunity is $10 Million, which is based on the revenue generated and high volume of scripts.
If you would like to learn more, please contact us for a Confidentiality Agreement that will allow us to share more detailed information with you.